Company Overview
Boltz builds open-source AI models for biomolecular structure and binding affinity prediction. MIT CSAIL spinout. $28M seed (Amplify, a16z, Zetta) + Pfizer collaboration. Boltz-1 matched AlphaFold3. Boltz-2 (June 2025, with Recursion): predicts structures AND binding affinities at 1000x speed. MIT-licensed.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Boltz is an emerging player bringing innovative solutions to the Healthcare Tech market.
Frequently Asked Questions
Compare Boltz with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Start Comparison →Claim This Profile
Are you from Boltz? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Boltz Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Boltz vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →